Urethral cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Urethral cancer}} | {{Urethral cancer}} | ||
{{CMG}} | {{CMG}};{{AE}}{{Vbe}} | ||
==Overview== | ==Overview== | ||
Revision as of 20:36, 20 June 2018
|
Urethral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urethral cancer differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Urethral cancer differential diagnosis |
|
Risk calculators and risk factors for Urethral cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Urethral cancer must be differentiated from bladder cancer, cervical cancer, bladder stones, ureteral stones, cystitis, neurogenic bladder, and urethritis.
Differentiation
Urethral cancer must be differentiated from the following diseases:
- Bladder cancer[1][2]
- Cervical cancer
- Bladder stones
- Urethrolithiasis
- Cystitis
- Neurogenic bladder
- Urethritis
References
- ↑ Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R (May 2013). "Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study". Urology. 81 (5): 1018–23. doi:10.1016/j.urology.2013.01.053. PMID 23608423.
- ↑ Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH (April 2017). "Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra". AJR Am J Roentgenol. 208 (4): 805–811. doi:10.2214/AJR.16.16929. PMID 28140610.